Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C

Journal of Hepatology

Volumn 33, Issue 5, 2000, Pages 812-817

  Solís Herruzo, José A ^a,b   Castellano, Gregorio ^a   Fernández, Inmaculada ^a   Muoz, Raquel ^a   Hawkins, Federico ^b  

^a Gastroenterology Department   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Bone loss; Osteopenia; Ribavirin

Indexed keywords

INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; BONE CELL; BONE DENSITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; DISEASE SEVERITY; FOLLOW UP; HEPATITIS C; HUMAN; MALE; OSTEOPENIA; PRIORITY JOURNAL; URINALYSIS;

EID: 0033758693     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80314-1     Document Type: Article

References (15)

1. Broad-spectrum antiviral activity of virazole: 1-beta-D-ribofuranosyl-1,2,4, triazole-3-carboxamide
2. Molecular action of ribavirin
3. Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis C
4. Ribavirin treatment for patients with chronic hepatitis C; results of a placebo-controlled study
5. Ribavirin as therapy for chronic hepatitis C
6. Tolerance and efficacy of oral ribavirin treatment of chronic hepatitis C. A multicenter trial
7. Interferon alpha 2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
8. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
9. Randomised trial of interferon α2b plus ribavirin for 48 weeks for treatment of chronic infection with hepatitis C virus
10. Therapy of hepatitis C. Alpha interferon and ribavirin
11. Formulation and application of a numeral scoring system for assessing histological activity in asymptomatic chronic active hepatitis
12. Bone mineral density in the Spanish population by dual X-ray absorptiometry (DEXA)